We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WAFD:NASDAQWaFd, Inc. Analysis

Data as of 2026-09-01 - not real-time

$35.76

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

The moving-average structure behind WaFd, Inc. is neutral at $35.76, with no clear ordering between short and long averages. Across the trailing 30 sessions it lost 2.9%. Momentum indicators put RSI at 33.0 (approaching oversold) with MACD reading bearish. Price has been bracketed by support at $35.60 and resistance at $38.27.
The shares look undervalued, trading on 11.4 times earnings below a sector average of 16.9. Sell-side targets cluster 9.1% above the current quote. Revenue is growing at 5.6% on a 33.7% profit margin. The 3.02% dividend yield looks covered by current payout levels.
Risk comes out at 3 of a possible 10, a low reading. With 30-day volatility of 12.9%, a beta of 0.50 and a maximum drawdown of 12.9%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 7 out of 10.

Top Market Events

WaFd cleared both top and bottom line estimates as active loan portfolios grew 10.WaFd, Inc. reported its third-quarter and nine-month results for the period ended June 30, 2026, showing year-over-year...What Happened? Shares of regional banking company WaFd NASDAQ:WAFD fell 3.4% in the afternoon session after the company...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 5/10

Key Factors

  • Trading above the 200-day average of 34.22
  • MACD momentum is negative
  • RSI at 33.0 is in neutral territory

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 11.4 versus sector average of 16.9
  • Trading above the 200-day average of 34.22
  • Analyst targets imply +9.1% versus the current price

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • P/E of 11.4 versus sector average of 16.9
  • Analyst targets imply +9.1% versus the current price
  • Profit margin of 33.7% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth5.60%
Profit Margin33.70%
P/E Ratio11.4
ROE8.50%
ROA0.94%
P/B Ratio1.0
Op. Cash Flow$267.5M
Industry P/E16.9

Technical Analysis

TrendNeutral
RSI33.0
Support$35.60
Resistance$38.27
MA 20$37.04
MA 50$37.35
MA 200$34.22
MACDBearish
VolumeDecreasing
Fear & Greed Index93.25

Valuation

Fair Value$4.77
Target Price$39.00
Upside/Downside9.06%
GradeUndervalued
TypeValue
Dividend Yield3.02%

Risk Assessment

Beta0.50
Volatility12.88%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.